Company Biophytis S.A.

Equities

ALBPS

FR0012816825

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Euronext Paris Other stock markets 11:35:20 2024-04-29 am EDT			5-day change	1st Jan Change
0.0024 ^EUR	+4.35%		+4.35%	-52.94%

Apr. 25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
Apr. 25	Top Premarket Decliners	MT

Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.

The company is located in Paris, France and Cambridge, Massachusetts.

Number of employees: 22

Managers	Title	Age	Since
Stanislas Veillet CEO	Chief Executive Officer	58	06-09-14
Nicolas Fellmann DFI	Director of Finance/CFO	55	23-05-21
Claudia Ferreira CTO	Chief Tech/Sci/R&D Officer	-	23-09-13
Rob van Maanen CTO	Chief Tech/Sci/R&D Officer	54	21-09-08
Pierre Dilda CTO	Chief Tech/Sci/R&D Officer	54	15-11-30
Waly Dioh CTO	Chief Tech/Sci/R&D Officer	55	06-09-14
Jean Mariani BRD	Director/Board Member	74	19-10-28
Edouard Bieth PRN	Corporate Officer/Principal	44	23-09-13
Chiara Baccelli PRN	Corporate Officer/Principal	48	22-12-31

Members of the board	Title	Age	Since
Nadine Coulm BRD	Director/Board Member	61	15-05-21
Claude Allary BRD	Director/Board Member	69	21-07-06
Stanislas Veillet CEO	Chief Executive Officer	58	06-09-14
Jean Mariani BRD	Director/Board Member	74	19-10-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,040,482,402	422,265,366 ( 40.58 %)	240,026 ( 0.0231 %)	40.58 %

Name	Equities	%	Valuation
Stanislas Veillet 2.860 %	32,775,471	2.860 %	123 891 €
Gestys SA 1.953 %	22,380,000	1.953 %	84 596 €
Waly Dioh 0.0215 %	246,316	0.0215 %	931 €
Lyxor International Asset Management SAS 0.0207 %	236,829	0.0207 %	895 €
Pierre Dilda 0.0124 %	142,308	0.0124 %	538 €
Ecofi Investissements SA 0.009248 %	105,980	0.009248 %	401 €
Rob van Maanen 0.006630 %	75,983	0.006630 %	287 €
Chiara Baccelli 0.006630 %	75,983	0.006630 %	287 €
Claresco Finance SA 0.002557 %	29,300	0.002557 %	111 €
Nadine Coulm 0.000109 %	1,250	0.000109 %	5 €

Name	Equities	%	Valuation
Morgan Stanley & Co. International Plc 0.0401 %	4,600	0.0401 %	1 615 €
RhumbLine Advisers LP 0.004625 %	530	0.004625 %	186 €

Biophytis SA

Sorbonne Université Bâtiment A 4 ème étage

75005, Paris

+33 1 44 27 23 00

http://www.biophytis.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BIOPHYTIS S.A.	-52.94%	2.81M
VERTEX PHARMACEUTICALS INCORPORATED	-2.65%	103B
REGENERON PHARMACEUTICALS, INC.	+1.75%	95.28B
ARGENX SE	+1.46%	22.15B
BIONTECH SE	-15.72%	21.02B
GENMAB A/S	-8.58%	18.15B
WUXI APPTEC CO., LTD.	-38.74%	16.73B
BEIGENE, LTD.	-12.47%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+5.43%	13.68B
SAREPTA THERAPEUTICS, INC.	+34.20%	12.17B

Bio Therapeutic Drugs